One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-10-12

AUTHORS

Goran Petrovski, Fawziya Al Khalaf, Judith Campbell, Fareeda Umer, Douha Almajaly, Manar Hamdan, Khalid Hussain

ABSTRACT

ObjectiveTo evaluate the effect of a 1-year hybrid closed-loop (HCL) system on glycemic control in children and adolescents with type 1 diabetes (T1D) previously treated with multiple daily injections (MDI). MethodsThis was a 1-year observational study, as a continuation of the previous 3 months prospective study of pediatric patients with T1D conducted at Sidra Medicine in Qatar. The study enrolled individuals aged 7–18 years with T1D > 1 year, on MDI with self-monitoring of blood glucose or continuous glucose monitoring, with no prior pump experience, and with an HbA1c level < 12.5% (< 113 mmol/mol). After the first 3 months of HCL use, patients were followed at 6, 9 and 12 months, where HbA1c was obtained and pump data were collected.ResultsAll 30 participants (age 10.24 ± 2.6 years) who initiated HCL completed 12 months of HCL system use in Auto Mode. The participants used the sensor 88.4 ± 6.5% of the time with Auto Mode usage 85.6 ± 7.4% during 12 months of HCL system use. HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). TIR (70–180 mg/dL) increased from 46.9% at baseline to 71.9% at 1 month and remained above 70% during the 12 months of HCL use.ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1 year following Auto Mode initiation. More... »

PAGES

207-213

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4

DOI

http://dx.doi.org/10.1007/s00592-020-01607-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1131624636

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33044604


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose Self-Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycemic Control", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin Infusion Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Education as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrovski", 
        "givenName": "Goran", 
        "id": "sg:person.015434126120.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015434126120.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al Khalaf", 
        "givenName": "Fawziya", 
        "id": "sg:person.01163400514.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163400514.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "Judith", 
        "id": "sg:person.015054523174.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015054523174.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Umer", 
        "givenName": "Fareeda", 
        "id": "sg:person.016316134111.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016316134111.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Almajaly", 
        "givenName": "Douha", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamdan", 
        "givenName": "Manar", 
        "id": "sg:person.013764004165.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013764004165.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hussain", 
        "givenName": "Khalid", 
        "id": "sg:person.01235717730.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235717730.67"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13300-018-0436-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103901307", 
          "https://doi.org/10.1007/s13300-018-0436-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-019-01472-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124151013", 
          "https://doi.org/10.1007/s00592-019-01472-w"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-10-12", 
    "datePublishedReg": "2020-10-12", 
    "description": "ObjectiveTo evaluate the effect of a 1-year hybrid closed-loop (HCL) system on glycemic control in children and adolescents with type 1 diabetes (T1D) previously treated with multiple daily injections (MDI).\nMethodsThis was a 1-year observational study, as a continuation of the previous 3\u00a0months prospective study of pediatric patients with T1D conducted at Sidra Medicine in Qatar. The study enrolled individuals aged 7\u201318\u00a0years with T1D\u2009>\u20091\u00a0year, on MDI with self-monitoring of blood glucose or continuous glucose monitoring, with no prior pump experience, and with an HbA1c level\u2009<\u200912.5% (<\u2009113\u00a0mmol/mol). After the first 3\u00a0months of HCL use, patients were followed at 6, 9 and 12\u00a0months, where HbA1c was obtained and pump data were collected.ResultsAll 30 participants (age 10.24\u2009\u00b1\u20092.6\u00a0years) who initiated HCL completed 12\u00a0months of HCL system use in Auto Mode. The participants used the sensor 88.4\u2009\u00b1\u20096.5% of the time with Auto Mode usage 85.6\u2009\u00b1\u20097.4% during 12\u00a0months of HCL system use. HbA1c decreased from 8.2\u2009\u00b1\u20091.4% (66\u2009\u00b1\u200915.3\u00a0mmol/mol) at baseline, to 6.7\u2009\u00b1\u20090.5% (50\u2009\u00b1\u20095.5\u00a0mmol/mol) at 3\u00a0months (p\u2009=\u20090.02) and remained stable to 7.1\u2009\u00b1\u20090.6 (54\u2009\u00b1\u20096.6\u00a0mmol/mol) at 12\u00a0months (p\u2009=\u20090.02). TIR (70\u2013180\u00a0mg/dL) increased from 46.9% at baseline to 71.9% at 1\u00a0month and remained above 70% during the 12\u00a0months of HCL use.ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1\u00a0year following Auto Mode initiation.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00592-020-01607-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1008525", 
        "issn": [
          "0940-5429", 
          "1432-5233"
        ], 
        "name": "Acta Diabetologica", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "58"
      }
    ], 
    "keywords": [
      "multiple daily injections", 
      "type 1 diabetes", 
      "hybrid closed-loop system", 
      "glycemic control", 
      "daily injections", 
      "HCL use", 
      "month prospective study", 
      "one-year experience", 
      "continuous glucose monitoring", 
      "pediatric patients", 
      "prospective study", 
      "blood glucose", 
      "glycemic outcomes", 
      "observational study", 
      "first month", 
      "successful outcome", 
      "Sidra Medicine", 
      "glucose monitoring", 
      "months", 
      "HbA1c", 
      "diabetes", 
      "patients", 
      "T1D", 
      "children", 
      "adolescents", 
      "baseline", 
      "outcomes", 
      "injection", 
      "years", 
      "participants", 
      "MethodsThis", 
      "ObjectiveTo", 
      "system use", 
      "study", 
      "control", 
      "glucose", 
      "use", 
      "medicine", 
      "experience", 
      "initiation", 
      "individuals", 
      "auto mode", 
      "levels", 
      "effect", 
      "monitoring", 
      "Qatar", 
      "TIR", 
      "data", 
      "time", 
      "continuation", 
      "system", 
      "HCl", 
      "drivers", 
      "mode", 
      "closed-loop system"
    ], 
    "name": "One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes", 
    "pagination": "207-213", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1131624636"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00592-020-01607-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33044604"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00592-020-01607-4", 
      "https://app.dimensions.ai/details/publication/pub.1131624636"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_838.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00592-020-01607-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      21 PREDICATES      99 URIs      89 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00592-020-01607-4 schema:about N26c6c880603e43d187c3fb8ad117cf37
2 N2758ecd69ccd4b78b07e20ca1948042d
3 N2e04fffc6be34e39aa13fdd95bd0bea7
4 N357e945afd784f1599eebe00af3eeac0
5 N7ad91d7725f54956a3886e16df4f29e9
6 N84059e16087d4f598c457b9ef6560cf5
7 N8545bceb0d9149939a195550a1c0cb7a
8 N8c8fb81afcf6417094f04614ac1d6c4a
9 N9a632366fe44456abb91b776e833ac3c
10 Na3bada4a2e6c4e5e89f2c1507a8da60d
11 Nab6d0c8f52e14403af5f68d7bba10772
12 Nae55b8fd5d4b4cc995e0dfc15b3782aa
13 Nce89fac1fc4f48ccb31a47cfec4d74cd
14 Ne0170877953b46d2969691920247a2fd
15 Ne3719c19b71b4b9b9b4541aadca37b87
16 Nf530c6ab2aee479089d53f8e953db638
17 Nfcd142ec3aa24cf0a6f932351f67571b
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N2ec8307ff6454434adf080372d79acd9
21 schema:citation sg:pub.10.1007/s00592-019-01472-w
22 sg:pub.10.1007/s13300-018-0436-y
23 schema:datePublished 2020-10-12
24 schema:datePublishedReg 2020-10-12
25 schema:description ObjectiveTo evaluate the effect of a 1-year hybrid closed-loop (HCL) system on glycemic control in children and adolescents with type 1 diabetes (T1D) previously treated with multiple daily injections (MDI). MethodsThis was a 1-year observational study, as a continuation of the previous 3 months prospective study of pediatric patients with T1D conducted at Sidra Medicine in Qatar. The study enrolled individuals aged 7–18 years with T1D > 1 year, on MDI with self-monitoring of blood glucose or continuous glucose monitoring, with no prior pump experience, and with an HbA1c level < 12.5% (< 113 mmol/mol). After the first 3 months of HCL use, patients were followed at 6, 9 and 12 months, where HbA1c was obtained and pump data were collected.ResultsAll 30 participants (age 10.24 ± 2.6 years) who initiated HCL completed 12 months of HCL system use in Auto Mode. The participants used the sensor 88.4 ± 6.5% of the time with Auto Mode usage 85.6 ± 7.4% during 12 months of HCL system use. HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). TIR (70–180 mg/dL) increased from 46.9% at baseline to 71.9% at 1 month and remained above 70% during the 12 months of HCL use.ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1 year following Auto Mode initiation.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf N3dfd0404f2f04b66a24dfdd7ccae53a2
29 Ne2d4bda3ba32455cba7f616ca097301d
30 sg:journal.1008525
31 schema:keywords HCL use
32 HCl
33 HbA1c
34 MethodsThis
35 ObjectiveTo
36 Qatar
37 Sidra Medicine
38 T1D
39 TIR
40 adolescents
41 auto mode
42 baseline
43 blood glucose
44 children
45 closed-loop system
46 continuation
47 continuous glucose monitoring
48 control
49 daily injections
50 data
51 diabetes
52 drivers
53 effect
54 experience
55 first month
56 glucose
57 glucose monitoring
58 glycemic control
59 glycemic outcomes
60 hybrid closed-loop system
61 individuals
62 initiation
63 injection
64 levels
65 medicine
66 mode
67 monitoring
68 month prospective study
69 months
70 multiple daily injections
71 observational study
72 one-year experience
73 outcomes
74 participants
75 patients
76 pediatric patients
77 prospective study
78 study
79 successful outcome
80 system
81 system use
82 time
83 type 1 diabetes
84 use
85 years
86 schema:name One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes
87 schema:pagination 207-213
88 schema:productId N1dfc8568c9e9445293afc95f06943d31
89 N315cacda4987418aaed3f7c20c081618
90 N5ce38a4ec5964d5c8034d5acfcded2a3
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1131624636
92 https://doi.org/10.1007/s00592-020-01607-4
93 schema:sdDatePublished 2022-09-02T16:03
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N8486e341685140518380e0cdb3ca37f7
96 schema:url https://doi.org/10.1007/s00592-020-01607-4
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N1a9adc740aef44379f3e5f97e616c137 rdf:first sg:person.01163400514.20
101 rdf:rest Nd8a366244996478a9604bf87b10b7957
102 N1dfc8568c9e9445293afc95f06943d31 schema:name doi
103 schema:value 10.1007/s00592-020-01607-4
104 rdf:type schema:PropertyValue
105 N248faa94020d4fafb6aa67da4f92d034 rdf:first N6fa22bffaa2242f0b68f387d86518113
106 rdf:rest Ne65057c89353461d95a6e598a199bd9d
107 N26c6c880603e43d187c3fb8ad117cf37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Blood Glucose
109 rdf:type schema:DefinedTerm
110 N2758ecd69ccd4b78b07e20ca1948042d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Patient Education as Topic
112 rdf:type schema:DefinedTerm
113 N2e04fffc6be34e39aa13fdd95bd0bea7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Treatment Outcome
115 rdf:type schema:DefinedTerm
116 N2ec8307ff6454434adf080372d79acd9 rdf:first sg:person.015434126120.67
117 rdf:rest N1a9adc740aef44379f3e5f97e616c137
118 N315cacda4987418aaed3f7c20c081618 schema:name pubmed_id
119 schema:value 33044604
120 rdf:type schema:PropertyValue
121 N357e945afd784f1599eebe00af3eeac0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Blood Glucose Self-Monitoring
123 rdf:type schema:DefinedTerm
124 N3dfd0404f2f04b66a24dfdd7ccae53a2 schema:issueNumber 2
125 rdf:type schema:PublicationIssue
126 N4c9bb0643ee24a979bbf38fc0d2f023b rdf:first sg:person.01235717730.67
127 rdf:rest rdf:nil
128 N5cc281cfebcf4a0c9b448127236475b9 rdf:first sg:person.016316134111.19
129 rdf:rest N248faa94020d4fafb6aa67da4f92d034
130 N5ce38a4ec5964d5c8034d5acfcded2a3 schema:name dimensions_id
131 schema:value pub.1131624636
132 rdf:type schema:PropertyValue
133 N6fa22bffaa2242f0b68f387d86518113 schema:affiliation grid-institutes:grid.467063.0
134 schema:familyName Almajaly
135 schema:givenName Douha
136 rdf:type schema:Person
137 N7ad91d7725f54956a3886e16df4f29e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Insulin Infusion Systems
139 rdf:type schema:DefinedTerm
140 N84059e16087d4f598c457b9ef6560cf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Diabetes Mellitus, Type 1
142 rdf:type schema:DefinedTerm
143 N8486e341685140518380e0cdb3ca37f7 schema:name Springer Nature - SN SciGraph project
144 rdf:type schema:Organization
145 N8545bceb0d9149939a195550a1c0cb7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Humans
147 rdf:type schema:DefinedTerm
148 N8c8fb81afcf6417094f04614ac1d6c4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Hypoglycemic Agents
150 rdf:type schema:DefinedTerm
151 N9a632366fe44456abb91b776e833ac3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Female
153 rdf:type schema:DefinedTerm
154 Na3bada4a2e6c4e5e89f2c1507a8da60d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Adolescent
156 rdf:type schema:DefinedTerm
157 Nab6d0c8f52e14403af5f68d7bba10772 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Prospective Studies
159 rdf:type schema:DefinedTerm
160 Nae55b8fd5d4b4cc995e0dfc15b3782aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Child
162 rdf:type schema:DefinedTerm
163 Nce89fac1fc4f48ccb31a47cfec4d74cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Male
165 rdf:type schema:DefinedTerm
166 Nd8a366244996478a9604bf87b10b7957 rdf:first sg:person.015054523174.35
167 rdf:rest N5cc281cfebcf4a0c9b448127236475b9
168 Ne0170877953b46d2969691920247a2fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Glycemic Control
170 rdf:type schema:DefinedTerm
171 Ne2d4bda3ba32455cba7f616ca097301d schema:volumeNumber 58
172 rdf:type schema:PublicationVolume
173 Ne3719c19b71b4b9b9b4541aadca37b87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Drug Administration Schedule
175 rdf:type schema:DefinedTerm
176 Ne65057c89353461d95a6e598a199bd9d rdf:first sg:person.013764004165.63
177 rdf:rest N4c9bb0643ee24a979bbf38fc0d2f023b
178 Nf530c6ab2aee479089d53f8e953db638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Injections
180 rdf:type schema:DefinedTerm
181 Nfcd142ec3aa24cf0a6f932351f67571b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Insulin
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
188 schema:name Clinical Sciences
189 rdf:type schema:DefinedTerm
190 sg:journal.1008525 schema:issn 0940-5429
191 1432-5233
192 schema:name Acta Diabetologica
193 schema:publisher Springer Nature
194 rdf:type schema:Periodical
195 sg:person.01163400514.20 schema:affiliation grid-institutes:grid.467063.0
196 schema:familyName Al Khalaf
197 schema:givenName Fawziya
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163400514.20
199 rdf:type schema:Person
200 sg:person.01235717730.67 schema:affiliation grid-institutes:grid.467063.0
201 schema:familyName Hussain
202 schema:givenName Khalid
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235717730.67
204 rdf:type schema:Person
205 sg:person.013764004165.63 schema:affiliation grid-institutes:grid.467063.0
206 schema:familyName Hamdan
207 schema:givenName Manar
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013764004165.63
209 rdf:type schema:Person
210 sg:person.015054523174.35 schema:affiliation grid-institutes:grid.467063.0
211 schema:familyName Campbell
212 schema:givenName Judith
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015054523174.35
214 rdf:type schema:Person
215 sg:person.015434126120.67 schema:affiliation grid-institutes:grid.467063.0
216 schema:familyName Petrovski
217 schema:givenName Goran
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015434126120.67
219 rdf:type schema:Person
220 sg:person.016316134111.19 schema:affiliation grid-institutes:grid.467063.0
221 schema:familyName Umer
222 schema:givenName Fareeda
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016316134111.19
224 rdf:type schema:Person
225 sg:pub.10.1007/s00592-019-01472-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1124151013
226 https://doi.org/10.1007/s00592-019-01472-w
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s13300-018-0436-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1103901307
229 https://doi.org/10.1007/s13300-018-0436-y
230 rdf:type schema:CreativeWork
231 grid-institutes:grid.467063.0 schema:alternateName Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar
232 schema:name Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...